214 related articles for article (PubMed ID: 23897818)
1. Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity.
Yin S; Zhang J; Mao Y; Hu Y; Cui L; Kang N; He W
J Biol Chem; 2013 Sep; 288(37):26448-62. PubMed ID: 23897818
[TBL] [Abstract][Full Text] [Related]
2. Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase.
Kim HS; Das A; Gross CC; Bryceson YT; Long EO
Immunity; 2010 Feb; 32(2):175-86. PubMed ID: 20189481
[TBL] [Abstract][Full Text] [Related]
3. The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.
Kong Y; Cao W; Xi X; Ma C; Cui L; He W
Blood; 2009 Jul; 114(2):310-7. PubMed ID: 19436053
[TBL] [Abstract][Full Text] [Related]
4. Cbl enforces Vav1 dependence and a restricted pathway of T cell development.
Chiang J; Hodes RJ
PLoS One; 2011 Apr; 6(4):e18542. PubMed ID: 21490975
[TBL] [Abstract][Full Text] [Related]
5. Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells.
Kim HS; Long EO
Sci Signal; 2012 Jul; 5(232):ra49. PubMed ID: 22786724
[TBL] [Abstract][Full Text] [Related]
6. Dephosphorylation of the adaptor LAT and phospholipase C-γ by SHP-1 inhibits natural killer cell cytotoxicity.
Matalon O; Fried S; Ben-Shmuel A; Pauker MH; Joseph N; Keizer D; Piterburg M; Barda-Saad M
Sci Signal; 2016 May; 9(429):ra54. PubMed ID: 27221712
[TBL] [Abstract][Full Text] [Related]
7. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
[TBL] [Abstract][Full Text] [Related]
8. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
[TBL] [Abstract][Full Text] [Related]
9. Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cells.
Poggi A; Zancolli M; Boero S; Catellani S; Musso A; Zocchi MR
Int J Cancer; 2011 Jul; 129(2):387-96. PubMed ID: 20853320
[TBL] [Abstract][Full Text] [Related]
10. CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells.
Niiro H; Jabbarzadeh-Tabrizi S; Kikushige Y; Shima T; Noda K; Ota S; Tsuzuki H; Inoue Y; Arinobu Y; Iwasaki H; Shimoda S; Baba E; Tsukamoto H; Horiuchi T; Taniyama T; Akashi K
Blood; 2012 Mar; 119(10):2263-73. PubMed ID: 22262777
[TBL] [Abstract][Full Text] [Related]
11. Vav1 oncogenic mutation inhibits T cell receptor-induced calcium mobilization through inhibition of phospholipase Cγ1 activation.
Knyazhitsky M; Moas E; Shaginov E; Luria A; Braiman A
J Biol Chem; 2012 Jun; 287(23):19725-35. PubMed ID: 22474331
[TBL] [Abstract][Full Text] [Related]
12. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.
Hernández-Caselles T; Miguel RC; Ruiz-Alcaraz AJ; García-Peñarrubia P
J Immunol Res; 2019; 2019():6032141. PubMed ID: 31143782
[TBL] [Abstract][Full Text] [Related]
13. NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.
Wilton KM; Overlee BL; Billadeau DD
J Cell Sci; 2019 Jul; 133(5):. PubMed ID: 31235500
[TBL] [Abstract][Full Text] [Related]
14. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
Wu X; Sharma A; Oldenburg J; Weiher H; Essler M; Skowasch D; Schmidt-Wolf IGH
Front Immunol; 2021; 12():731767. PubMed ID: 34691037
[TBL] [Abstract][Full Text] [Related]
15. New insights into the Vav1 activation cycle in lymphocytes.
Barreira M; Rodríguez-Fdez S; Bustelo XR
Cell Signal; 2018 May; 45():132-144. PubMed ID: 29410283
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS
Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453
[TBL] [Abstract][Full Text] [Related]
17. Impaired T-cell development in the absence of Vav1 and Itk.
Raberger J; Boucheron N; Sakaguchi S; Penninger JM; Ellmeier W
Eur J Immunol; 2008 Dec; 38(12):3530-42. PubMed ID: 19009524
[TBL] [Abstract][Full Text] [Related]
18. RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses.
Ruiz S; Santos E; Bustelo XR
Mol Cell Biol; 2007 Dec; 27(23):8127-42. PubMed ID: 17923690
[TBL] [Abstract][Full Text] [Related]
19. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
[TBL] [Abstract][Full Text] [Related]
20. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.
Hosomi S; Chen Z; Baker K; Chen L; Huang YH; Olszak T; Zeissig S; Wang JH; Mandelboim O; Beauchemin N; Lanier LL; Blumberg RS
Eur J Immunol; 2013 Sep; 43(9):2473-83. PubMed ID: 23696226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
